4//SEC Filing
ARATANA THERAPEUTICS, INC. 4
Accession 0001209191-15-023723
CIK 0001509190operating
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 6:31 PM ET
Size
5.5 KB
Accession
0001209191-15-023723
Insider Transaction Report
Form 4
Vander Vort John
Director10% Owner
Transactions
- Sale
Common Stock
2015-03-06$20.01/sh−6,137$122,776→ 25,000 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2014.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]Includes 7,070 shares that were distributed pro rata to the Reporting Person by entities affiliated with MPM BioVentures V, L.P. These shares were previously reported as indirectly held by Reporting Person.
Documents
Issuer
ARATANA THERAPEUTICS, INC.
CIK 0001509190
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001509190
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 6:31 PM ET
- Size
- 5.5 KB